Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

RESTANCE to Use $9 Billion Market Momentum in Strategy to Help End Aids Epidemic

Posted on: 14 Nov 17
RESTANCE to Use $9 Billion Market Momentum in Strategy to Help End Aids Epidemic

PR Newswire

SPARKS, Nevada, November 14, 2017

SPARKS, Nevada, November 14, 2017 /PRNewswire/ --

RESTANCE, Inc. (USOTC: ANCE) today announced plans to introduce a strategic marketing campaign on December 1, 2017 in conjunction with World Aids Day. The campaign is designed to contribute to the United Nations goal of ending the AIDS Epidemic.  RESTANCE plans to contribute to the UN goal to end the AIDS Epidemic by making condoms available everywhere in Africa through the previously announced #DoItForAfrica buy-one-give-one campaign where an anticipated $20 million in condoms will be sold in North American and for every condom sold, a condom will be manufactured in Africa and given away in Africa.

RESTANCE -  $20 Million Revenue #DoItForAfrica Campaign 

RESTANCE has acquired the tools to equip a condom manufacturing plant and plans to open a condom manufacturing plant in Kenya soon to produce condoms for all Africa. RESTANCE has secured a contract where the company will produce condoms under a major, globally recognized brand name in conjunction with the #DoItForAfrica buy-one-give-one campaign.  The #DoItForAfrica campaign is anticipated to generate $20 million in revenue. The company plans to announce the brand name contract in conjunction with World Aids Day on December 1, 2017.

RESTANCE is pursuing several business lines in the growing economies of East Africa. The Company is developing opportunities in the region including initiatives in technology and systems integration services, utility support services, affordable housing and health products manufacturing. RESTANCE recently acquired East African Development Partners as part of its strategy in East Africa.

Learn more about the RESTANCE operations in Africa on the Company's website:

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

UNAIDS World Aids Day Campaign - My Health, My Right

Learn more about the UN goals to end the World Aids Epidemic and the UNAIDS 2017 World Aids Day Campaign - My Health, My Right:

Or Contact:
Sophie Barton-Knott
tel. +41-22-791-1697

Media Contact:
Randell Torno 


PR Newswire

Last updated on: 14/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.